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ABSTRACT : From 1967 through 1987, 43 of primary malignant tumors of the 
small intestine were experienced at the First Department of Surgery, Nagasaki Uni-
versity Hospital and affiliated hospital, and clinically analysed. 
1) Carcinoma, leiomyosarcoma and malignant lymphoma occupied one third in 
   number. The preferable location of carcinomas and malignant lymphomas was
   lower part of the small bowel although that of leiomyosarcoma was upper part. 
2) Diagnosis was mainly made by means of laparotomy which was carried out by 
   clinical signs of obstruction or peritonitis. poor prognosis attributed to exten-
   sion of a disease to nodes and liver. An early and accurate diagnosis of small 
   bowel tumors is necessary for improving the survival rate.
       INTRODUCTION 
 Primary tumors of the small intestine are 
very rare in frequency as reported to be 3-6% 
of gastrointestinal neoplasmal) and also about 
1.5- 5 % of all gastrointestinal malignant tu-
mors. Sixty and 75% of these are malignant, 
although it corresponds to approximately 1 % 
of malignant tumors.2)3) 
 Because of the infrequency and non-specific 
symptoms of small bowel tumors, improved 
management can hardly be achieved. 
 The present study analyzes the experience 
with 43 malignant small bowel tumors at the 
First Dept. of Surgery, Nagasaki University 
School of Medicine and its affiliated hospitals.
   MATERIAL AND RESULTS 
 Forty-three malignant tumors constituted 
24 carcinomas, 30 leiomyosarcomas and 32 ma-
lignant lymphomas. Periampullary neoplasmas 
and those of ileocecal valve were excluded 
from this study. There were 25 males and 18 
females. 
 The age of patients ranged from 18 to 79 
years (mean 52.6) , averaging 63.7 years in 
carcinomas, 58.7 in leiomyosarcomas and 53.8 
in malignant lymphomas as shown in Fig 1. 
Almost half of carcinomas were localized in 
the lower portion of the small bowel and one 
third in lower part. Sixty-seven per cent of leio-
myosarcomas were situated in the upper por-
tion. On the contrary, ninty-four per cent of 
malignant lymphomas were localized in the
age aistribution 41 : male : female
Fig. 1. Sex & Age distribution in 43 primary ma-
      lignant small bowel tumors 
lower part with the individual preferential 
location. 
 Abdominal pain, anemia and abdominal mass 
were the most common symptoms, other symp-
toms were ileus, weight loss, melena and per-
foration. Non-specific symptoms of abdominal 
pain and anemia were common. 
 The diagnosis preoperatively made was 
shown in Table 1. Obstruction with unknown 
origin and abdominal neoplasms were of diag-
nostic importance when the sign of the intestin-
al obstruction was manifest and abdominal 
mass was palpated. Abdominal pain, ileus, ane-
mia and palpation of abdominal mass were 
common in frequency of clinical signs in malig-
nant neoplasms including carcinomas, leiomyo-
mas and malignant lymphomas as shown in Ta-
ble 1.
Table 1. Tumor location in 4 3 primary malig-
       nant tumors of the small bowel 
 location carcinoma leiomyo- malig. total 
                   sarcoma lymphoma 
 upper 206.7) 10(66.7) 1 ( 6.3) 13(30.2) 
 middle 4(33.3) 3(20.0) 0 7(16.3) 
 lower 6(50.0) 2(13.3) 15(93.8) 23(53.5) 
 total 12(100%) 15(100%) 16(100%) 43(100%)
 The most valuable means to detect was bar-
ium enema, CT scan and ultrasonography. 
These were of benefit to exclude a pancreatic 
origin of the neoplasm and to evaluate the 
locoregional diffusion. 
 Resection was performed in all patients. In 
the two out of 12 carcinomas, one had hepatic 
metastasis and the other had peritoneal dissem-
ination accompanying perforation with hepatic 
metastasis. In the two out of seven malignant 
lymphosarcoma, involvement of the abdominal 
wall was seen in either case. 
 In leiomyosarcoma, there were hepatic met-
astasis in one and peritoneal dissemination in 
another one, respectively. 
 Operative mortality was 6.9% (3 patients 
died within 30 days after surgery among the 24 
cases). Positive nodes were found in 12 pa-
tients resected for malignancy. Ten of whom 
was carcinoma. The survival of the 24 patients 
has been analysed as shown in Table 2. 
Table 2. Clinical signs in 43 primary malignan-
       cy of the small intestine
         carcinoma leiomyo- malig, total 
                  sarcoma lymphoma 
abd, pain 41.7%(5/12) 46.7%(7/15) 81.3%(13/16) 58.l%(25/43) 
 ileus 58.3 (7/12) 20.0 (3/15) 37.5 ( 6/16) 37.2 (16/43) 
abd, mass 50.0 (6/12) 50.0 (7/14) 63.6 ( 7/11) 54.1 (20/37) 
 anemia 66.7 (8/12) 53.3 (8/15) 56.3 ( 9/16) 58.1 (25/43) 
 melena 16.7 (2/12) 6.7 (1/15) 18.8 ( 3/16) 14.0 ( 6/43) 
weight loss 25.0 (3/12) 6.7 (1/15) 18.8 ( 3/16) 16.3 ( 7/43) 
perforation 0 (0/12) 20.0 (3/15) 6.3 ( 1/16) 9.3 ( 4/43)
 The survival in those who have carcinomas 
and malignant lymphomas could not extend af-
ter surgery as would be expected. (Fig. 2) It 
was based on the advancing disease stages in-
volving the nodes and peritoneal infiltration, 
and metastasizing into the liver. 
 Poor prognosis was shown as death within 
two years following surgery. The patients who 
survived over two years after surgery. with re-
spect to histological type, a most detrimental 
outcome was shown in poorly differentiated 
carcinoma and diffuse lymphoblastic cell type 
of malinant lymphoma. Whenever the survival 
extended up to five years, the longer survivor 
should be expected. 
        DISCUSSION 
 It is very rare to have a chance to treat tu-
mors of the small intestine. 4) It has been pro-
posed that exposure of any potent carcinogen 
to the mucosa is transient on account of rapid 
transit of small bowel contents. 5)
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Fig. 2. Relationship between histologic types and surgi;bal outcome.
 Improved management can not be achieved 
by less experience with diagnosis and treat-
ment. Furthermore, the non-specific symptoms 
of small bowel tumors delay diagnosis and 
make it impossible to curatively treat. 
 Radiological examination of the gastro-
intestinal tract is useful for diagnosis in a lim-
ited number of cases.2)6) Needless to say, early 
detection by barium study is infrequently a-
chieved, so are ultrasonography and CT scan 
attempted in combination. 
 Both sometimes help to ascertain the site 
and the spread of a tumor. In general, many 
surgeons tend to point out poor survival rate 
among patients with longer duration of symp-
toms. 6) "" 8) In this series a tumor was spread-
ing into the adjacent organ, nodes and 
the liver in 57.2% of malignant lymphosar-
comas, in 83.4% of carcinoma and in 33.3% of 
leiomyosarcoma. Survival is correlated with 
the histologic type of malignant neoplasia in 
some extent. However, it is natural to expect 
that those who survive over two years fol-
lowing surgery should be a long survivors. Clin-
ical symptoms such as obstruction and abdom-
inal mass, which are a diagnostic clue imply al-
ready far advancing disease. On the conse-
quence, an early and accurate diagnosis of 
small bowel tumors is needed for improvement 
of surgical outcome. In patients undergoing 
resection for malignant neoplasms, survival is 
related to histological type and extension of a 
tumor.
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